Released Sep 16, 2013, after the close
10-Q filed Sep 16, 2013, 47 days after period end · 0001354488-13-005238
Q3 2013 · 10-Q
Revenue—
Net Income$1.25M$1.25M −2.3% vs Q3 2012−10.1% vs Q2 2013
EPS Diluted$0.05$0.05 −5.4% vs Q3 2012−10.2% vs Q2 2013
Gross Profit$2,980,052+14.7%
Operating Income$1,533,425−2.5%
Operating Cash Flow$690,664−39.6%
Free Cash Flowderived$615,034−43.2%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | $1.25M | $1.28M | $1.50M | $121.41K |
| EPS Diluted | $0.05 | $0.06 | $0.07 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR